Literature DB >> 23009322

Equine bone marrow-derived mesenchymal stromal cells (BMDMSCs) from the ilium and sternum: are there differences?

M K Adams1, L R Goodrich, S Rao, F Olea-Popelka, N Phillips, J D Kisiday, C W McIlwraith.   

Abstract

REASONS FOR PERFORMING STUDY: The 2 sites of bone marrow harvest for isolation of mesenchymal stromal cells (MSC) in the horse are the sternum and ilium. The technical procedure is based on practitioner preference, but no studies have compared MSC concentrations and growth rates between the sites in horses aged 2-5 years.
OBJECTIVES: The objective of this study was to compare nucleated cell counts and growth rates between the sternum and ilium and between consecutive 5 ml bone marrow aspirates. We hypothesised that there would be a higher concentration of MSCs in the sternum than the ilium, and that the first sequential aspirate from either site would yield the greatest concentration of MSCs. We hypothesised that growth rates of cells from each site would not differ.
METHODS: Seven horses, aged 2 to 5 years, had 2 sequential 5 ml marrow aspirates taken from the sternum and ilium. Nucleated cell counts (NCCs) were obtained before and after marrow processing. Cells were expanded in culture for 3 passages and growth rate characteristics compared for all aspirates.
RESULTS: The NCCs of the first 5 ml aspirate were higher than those of the second 5 ml aspirate for both sites (P<0.05). There was no difference between growth rates for any of the groups (P>0.05).
CONCLUSIONS: The NCCs and growth rates of progenitor cells in the ilium and sternum are similar for horses in the 2-5 year age category. The first 5 ml bone marrow aspirate has a higher concentration of NCCs and resulting bone marrow-derived MSC population than subsequent aspirates. POTENTIAL RELEVANCE: The first 5 ml aspirates from the sternum and ilium offer a rich supply of bone marrow-derived MSCs with similar growth rate characteristics. The harvesting procedure of only a 5 ml draw from either the sternum or ilium should result in adequate numbers of MSCs.
© 2012 EVJ Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23009322      PMCID: PMC3581704          DOI: 10.1111/j.2042-3306.2012.00646.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  12 in total

1.  Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.

Authors:  R K W Smith; M Korda; G W Blunn; A E Goodship
Journal:  Equine Vet J       Date:  2003-01       Impact factor: 2.888

2.  Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn?

Authors:  R K W Smith; P M Webbon
Journal:  Br J Sports Med       Date:  2005-09       Impact factor: 13.800

3.  In vitro heterogeneity of osteogenic cell populations at various equine skeletal sites.

Authors:  Laurie A McDuffee; Gail I Anderson; Glenda M Wright; Daniel A J Ryan
Journal:  Can J Vet Res       Date:  2006-10       Impact factor: 1.310

4.  Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue.

Authors:  Chrisoula A Toupadakis; Alice Wong; Damian C Genetos; Whitney K Cheung; Dori L Borjesson; Gregory L Ferraro; Lawrence D Galuppo; J Kent Leach; Sean D Owens; Clare E Yellowley
Journal:  Am J Vet Res       Date:  2010-10       Impact factor: 1.156

5.  Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume.

Authors:  G F Muschler; C Boehm; K Easley
Journal:  J Bone Joint Surg Am       Date:  1997-11       Impact factor: 5.284

6.  Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised study.

Authors:  C Fortanier; M Kuentz; L Sutton; N Milpied; M Michalet; G Macquart-Moulin; C Faucher; A G Le Corroller; J P Moatti; D Blaise
Journal:  Bone Marrow Transplant       Date:  2002-01       Impact factor: 5.483

7.  Comparison of bone marrow aspiration at the sternum and the tuber coxae in middle-aged horses.

Authors:  Uta Delling; Katrin Lindner; Iris Ribitsch; Henriette Jülke; Walter Brehm
Journal:  Can J Vet Res       Date:  2012-01       Impact factor: 1.310

8.  Transpedicular aspiration of osteoprogenitor cells from the vertebral body: progenitor cell concentrations affected by serial aspiration.

Authors:  Robert F McLain; Cynthia A Boehm; Candace Rufo-Smith; George F Muschler
Journal:  Spine J       Date:  2009-12       Impact factor: 4.166

9.  The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells.

Authors:  J U Yoo; T S Barthel; K Nishimura; L Solchaga; A I Caplan; V M Goldberg; B Johnstone
Journal:  J Bone Joint Surg Am       Date:  1998-12       Impact factor: 5.284

10.  Aspiration of osteoprogenitor cells for augmenting spinal fusion: comparison of progenitor cell concentrations from the vertebral body and iliac crest.

Authors:  Robert F McLain; James E Fleming; Cynthia A Boehm; George F Muschler
Journal:  J Bone Joint Surg Am       Date:  2005-12       Impact factor: 6.558

View more
  9 in total

1.  Evaluation of adipose-derived stromal vascular fraction from the lateral tailhead, inguinal region, and mesentery of horses.

Authors:  Garrett L Metcalf; Scott R McClure; Jesse M Hostetter; Rudy F Martinez; Chong Wang
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

2.  Biologic Treatments for Sports Injuries II Think Tank-Current Concepts, Future Research, and Barriers to Advancement, Part 3: Articular Cartilage.

Authors:  Jason P Zlotnicki; Andrew G Geeslin; Iain R Murray; Frank A Petrigliano; Robert F LaPrade; Barton J Mann; Volker Musahl
Journal:  Orthop J Sports Med       Date:  2016-04-15

3.  Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics.

Authors:  Lucinara Dadda Dias; Karina Rabello Casali; Carine Ghem; Melissa Kristocheck da Silva; Grasiele Sausen; Patrícia Bonini Palma; Dimas Tadeu Covas; Renato A K Kalil; Beatriz D Schaan; Nance Beyer Nardi; Melissa Medeiros Markoski
Journal:  J Transl Med       Date:  2017-07-25       Impact factor: 5.531

4.  Combined Analysis of Endothelial, Hematopoietic, and Mesenchymal Stem Cell Compartments Shows Simultaneous but Independent Effects of Age and Heart Disease.

Authors:  Carine Ghem; Lucinara Dadda Dias; Roberto Tofani Sant'Anna; Renato A K Kalil; Melissa Markoski; Nance Beyer Nardi
Journal:  Stem Cells Int       Date:  2017-07-27       Impact factor: 5.443

5.  Sternal bone marrow derived equine multipotent mesenchymal stromal cells (MSCs): investigations considering the sampling site and the use of different culture media.

Authors:  Carina Eydt; Florian Geburek; Carmen Schröck; Nina Hambruch; Karl Rohn; Christiane Pfarrer; Carsten Staszyk
Journal:  Vet Med Sci       Date:  2016-06-20

Review 6.  Bioaugmentation in the surgical treatment of anterior cruciate ligament injuries: A review of current concepts and emerging techniques.

Authors:  Austin MacFarland Looney; Joseph Daniel Leider; Andrew Ryan Horn; Blake Michael Bodendorfer
Journal:  SAGE Open Med       Date:  2020-05-12

7.  An Investigation of Equine Mesenchymal Stem Cell Characteristics from Different Harvest Sites: More Similar Than Not.

Authors:  Karla G Lombana; Laurie R Goodrich; Jennifer Nikki Phillips; John David Kisiday; Audrey Ruple-Czerniak; C Wayne McIlwraith
Journal:  Front Vet Sci       Date:  2015-12-07

8.  Cryopreservation of equine mesenchymal stem cells in 95% autologous serum and 5% DMSO does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95% and DMSO at 10 or 5.

Authors:  Alexis Mitchell; Kristen A Rivas; Roger Smith; Ashlee E Watts
Journal:  Stem Cell Res Ther       Date:  2015-11-26       Impact factor: 6.832

Review 9.  Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know.

Authors:  Sophie Helen Bogers
Journal:  Front Vet Sci       Date:  2018-04-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.